ARCHIVES

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007

FDA Approves Genetic Test For Breast Cancer Patients

January 25, 2008

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50

August 27, 1976

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

ANG1005 Demonstrates Activity In Patients with Brain Metastases

November 29, 2013